Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Elisa Biasco"'
Autor:
Sergio Baldari, Elisa Biasco, Matteo Salgarello, Stefano Fanti, Orazio Caffo, Pierpaolo Alongi, Gaetano Facchini, Enrico Cortesi, Viviana Frantellizzi, Eugenio Borsatti, Giuseppe De Vincentis, Fabio Monari, Roberto Bortolus, Alessandra Murabito, Angelina Filice, Clizia Zichi, Renato Costa, Salvatore Antonio Pignata, Andrea Sbrana, Massimiliano Spada, Carmine Pinto, Filippo Alongi, Marcello Tucci, Antonio Palermo
Background: Radium 223 (RA223) is currently administered as part of a therapeutic sequence with the other life-prolonging agents (LPAs) for metastatic castration-resistant prostate cancer (mCRPC). Patients & methods: We retrospectively reviewed the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4f40ca1336d91555d8baa47a12b1ff
http://hdl.handle.net/11570/3193900
http://hdl.handle.net/11570/3193900
Autor:
Clizia Zichi, Pierpaolo Alongi, Salvatore Antonio Pignata, Luca Galli, Stefania Agostini, Massimiliano Spada, Sabrina Rossetti, Fabio Monari, Angelina Filice, Sergio Baldari, Elisa Biasco, Viviana Frantellizzi, Giuseppe De Vincentis, Marcello Tucci, Eugenio Borsatti, Cristina Masini, Enrico Cortesi, Gaetano Facchini, Stefano Fanti, Roberto Bortolus, Orazio Caffo
Purpose: To evaluate the fracture risk and survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) who received sequentially abiraterone acetate (AA) and radium 223 [223Ra]RaCl2 in the daily clinical practice. Mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d0b3ca0a0fbbbd5fa795a02db6b862
http://hdl.handle.net/11570/3195721
http://hdl.handle.net/11570/3195721
Autor:
Daniele Santini, Silvia Spoto, Luca Galli, Sebastiano Buti, Andrea Camerini, Giuseppe Procopio, A. Farnesi, Rossana Berardi, Marco Maruzzo, Giuseppe Tonini, Linda Cerbone, Giuseppe Di Lorenzo, Cora N. Sternberg, Michelle Sterpi, Delia De Lisi, Raffaele Ratta, Ugo De Giorgi, Mariangela Torniai, Elisa Biasco, Francesco Massari, Francesco Pantano
Publikováno v:
Oncotarget
// Daniele Santini 1 , Raffaele Ratta 2 , Francesco Pantano 1 , Delia De Lisi 1 , Marco Maruzzo 3 , Luca Galli 4,6 , Elisa Biasco 4 , Azzurra Farnesi 4 , Sebastiano Buti 5 , Cora Nanette Sternberg 6 , Linda Cerbone 6 , Giuseppe Di Lorenzo 7 , Silvia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb75461e4bb24f0ce01b3683084d68fa
https://doi.org/10.18632/oncotarget.20022
https://doi.org/10.18632/oncotarget.20022
Autor:
Ugo De Giorgi, Paolo Marchetti, Delia De Lisi, Camillo Porta, Maurizio Nicodemo, Marco Maruzzo, Bruno Vincenzi, Elena Verzoni, Rodolfo Montironi, Daniele Santini, Francesco Massari, Sebastiano Buti, Luca Galli, Alessandro Conti, Giuseppe Procopio, Giuseppe Tonini, Giovanni Muto, Elisa Biasco, Rocco Papalia, Giuseppe Di Lorenzo, Matteo Santoni, Riccardo Ricotta, Rossana Berardi, Luciano Burattini, Emanuela Altobelli, Stefano Cascinu
Publikováno v:
Oncotarget
// Daniele Santini 1 , Matteo Santoni 2 , Alessandro Conti 3 , Giuseppe Procopio 4 , Elena Verzoni 4 , Luca Galli 5 , Giuseppe di Lorenzo 6 , Ugo De Giorgi 7 , Delia De Lisi 1 , Maurizio Nicodemo 8 , Marco Maruzzo 9 , Francesco Massari 10 , Sebastian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55bd5ee6602a891316fc35e14dfeee41
http://europepmc.org/articles/PMC5078103
http://europepmc.org/articles/PMC5078103
Autor:
Cristina Masini, Pierpaolo Alongi, Gaetano Facchini, Orazio Caffo, Stefano Fanti, Roberto Bortolus, M. Spada, Clizia Zichi, Salvatore Antonio Pignata, Eugenio Borsatti, Sabrina Rossetti, Marcello Tucci, Enrico Cortesi, Viviana Frantellizzi, Angelina Filice, Giuseppe De Vincentis, Luca Galli, Sergio Baldari, Elisa Biasco, Fabio Monari
Publikováno v:
Publons
e17593 Background: The increased incidence of bone fractures found in pts who received the AA-RA223 combination compared to those treated with AA alone in the ERA223 trial led to restrictive recommendations by the European Medicines Agency which limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5b551a2165426d692dccda3da013de
https://doi.org/10.1200/jco.2020.38.15_suppl.e17593
https://doi.org/10.1200/jco.2020.38.15_suppl.e17593
Autor:
Francesco Atzori, Roberto Sabbatini, Ugo De Giorgi, Elisa Biasco, Riccardo Ricotta, Luca Galli, Paolo Andrea Zucali, Giuseppe Fornarini, Francesco Massari, Nicole Gri, Elena Verri, Sebastiano Buti, Alessandra Mosca, Camillo Porta, Roberto Iacovelli, Chiara Miggiano, Franco Nolè, Cristina Masini, Cristian Lolli, Gaetano Facchini, Giampaolo Tortora, Daniele Santini, Maria Giuseppa Vitale
Publikováno v:
Urologic oncology. 37(8)
Objectives To investigate if a first-line treatment delay (TD) can negatively affect the outcomes of patients affected by metastatic renal cancer. Patients and methods Patients with a diagnosis of metastatic renal cancer who were ineligible for activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46868318ce8ee464b623f9a487e1df3
https://pubmed.ncbi.nlm.nih.gov/31656764
https://pubmed.ncbi.nlm.nih.gov/31656764
Autor:
Sergio Ricci, Andrea Sbrana, Elisa Biasco, Andrea Antonuzzo, Federico Paolieri, Luca Galli, Gianna Musettini
Publikováno v:
Tumori. 104(6)
Introduction: Basal cell carcinoma (BCC) is the most common skin cancer. Treatment options for metastatic or locally advanced BCC inappropriate for surgery or radiotherapy were poor until vismodegib was approved for use in this setting. This drug can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041c3f57564aeff5de8bb0d9a5ddab0a
https://pubmed.ncbi.nlm.nih.gov/29895211
https://pubmed.ncbi.nlm.nih.gov/29895211
Autor:
Franco Morelli, Cristina Masini, Giuseppe Fornarini, Andrea Sbrana, Beatrice Detti, Roberto Iacovelli, Ugo De Giorgi, Alessandra Mosca, Erica Palesandro, Federico Paolieri, Elisa Biasco, Daniele Santini, Claudia Caserta, Luca Galli
Publikováno v:
Anticancer research. 38(8)
BACKGROUND/AIM The specific characteristics of patients who are most likely to benefit from pazopanib therapy are still uncertain. We report on the results of an Italian multicenter, retrospective analysis investigating the factors associated with lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6feb41b73913860a385007c80e96aff3
https://pubmed.ncbi.nlm.nih.gov/30061269
https://pubmed.ncbi.nlm.nih.gov/30061269
Autor:
Roberto Sabbatini, Luca Galli, Cristian Lolli, Ugo De Giorgi, Ilaria Toscani, Sebastiano Buti, Giampaolo Tortora, Chiara Miggiano, Giulia Carlo-Stella, Daniele Santini, Elisabetta Nobili, Riccardo Ricotta, Francesco Atzori, Elisa Biasco, Giuseppe Fornarini, Alessandra Mosca, Cristina Masini, Camillo Porta, Carlo Terrone, Melissa Bersanelli, Alessandro Pastorino, Delia De Lisi, Roberto Iacovelli, Franco Nolè, Paolo Andrea Zucali, Gaetano Facchini, Annalisa Guida, Francesco Massari, Sabrina Rossetti, Maria Cossu Rocca, Mario Scartozzi, Carmine Pinto
We aimed to investigate the different outcomes in patients with metastatic renal cell carcinoma treated with second-line axitinib or everolimus after sunitinib. Patients treated in 16 oncological centres in Italy were included, and those receiving ax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f8bca1f736662fe165a3cf5940c731
http://hdl.handle.net/11567/915648
http://hdl.handle.net/11567/915648
Autor:
G. Jenster, Ron H.N. van Schaik, Eleonora Rofi, Mario Miccoli, Stefania Crucitta, Lisa Derosa, Cinzia Orlandini, Luca Galli, Marzia Del Re, Elisa Biasco, Romano Danesi, Alfredo Falcone
Publikováno v:
European Urology, 73(1), E11-E12. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b0ec797558b0bc52a98d92808ab0ca
http://hdl.handle.net/11568/883959
http://hdl.handle.net/11568/883959